LORFILL
Live / Applied — Statement of use — registration review complete (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 25 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98871041
- Mark type
- Stylized text
- Filed
- 25 Nov 2024
- Published for opposition
- 08 Jul 2025
- Attorney of record
- David M. Tener, Esq.
Goods and services
- Class 044 — Medical, beauty and agricultural services: Cosmetic and plastic surgery; Medical services, namely, penile enlargement procedures and scrotal enlargement procedures
Owner
- Loria Pharmaceutical, LLC, Doral, FL, US
- Loria Pharmaceutical, LLC, Doral, FL, US
Prosecution history
- 31 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Sept 2025 — USE AMENDMENT FILED
- 28 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED